Quantitative Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
+5,999
New +$1.07M 0.15% 185
2026
Q1
Sell
-3,120
Closed -$622K 414
2025
Q4
$622K Buy
3,120
+342
+12% +$62K 0.06% 285
2025
Q3
$434K Buy
+2,778
New +$441K 0.06% 246
2024
Q4
Sell
-4,848
Closed -$954K 350
2024
Q3
$954K Sell
4,848
-5,910
-55% -$1.23M 0.09% 176
2024
Q2
$2.22M Buy
+10,758
New +$2.44M 0.24% 85
2022
Q4
Sell
-1,707
Closed -$335K 228
2022
Q3
$335K Sell
1,707
-3,086
-64% -$666K 0.06% 229
2022
Q2
$1.02M Buy
4,793
+3,511
+274% +$858K 0.16% 126
2022
Q1
$364K Buy
+1,282
New +$395K 0.04% 158
2020
Q1
Sell
-16,675
Closed -$2.55M 566
2019
Q4
$2.55M Buy
+16,675
New +$2.31M 0.08% 266
2018
Q3
Sell
-10,600
Closed -$1.19M 681
2018
Q2
$1.19M Buy
+10,600
New +$1.15M 0.02% 457
2018
Q1
Sell
-13,600
Closed -$1.49M 773
2017
Q4
$1.49M Sell
13,600
-52,300
-79% -$5.69M 0.02% 561
2017
Q3
$7.12M Buy
65,900
+62,000
+1,590% +$6.37M 0.08% 276
2017
Q2
$394K Buy
+3,900
New +$359K 0.01% 633
2016
Q3
Sell
-24,900
Closed -$2.05M 696
2016
Q2
$2.05M Buy
24,900
+21,900
+730% +$1.8M 0.1% 286
2016
Q1
$227K Buy
+3,000
New +$222K 0.01% 677
2015
Q2
Sell
-5,500
Closed -$436K 492
2015
Q1
$436K Buy
+5,500
New +$406K 0.04% 383

Other funds holding CRL

Quantitative Investment Management's CRL Position: Q2 2026 in Review

Quantitative Investment Management opened a new position in Charles River Laboratories (CRL) in Q2 2026: 5,999 shares worth $1.36M. The stake represents 0.15% of the portfolio and ranks #185 among its holdings. This is a return to the name: Quantitative Investment Management previously reported a position in CRL as recently as Q4 2025.

Quantitative Investment Management first reported a position in CRL in Q1 2015 and has held it in 16 quarters since. The position peaked at $7.12M in Q3 2017. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Quantitative Investment Management held 5,999 shares of Charles River Laboratories worth $1.36M as of Q2 2026.
  • Charles River Laboratories was a new Quantitative Investment Management position in Q2 2026.
  • Charles River Laboratories made up 0.15% of Quantitative Investment Management's portfolio in Q2 2026, its #185 holding.
  • Quantitative Investment Management first reported a position in Charles River Laboratories in Q1 2015 and has held it in 16 quarters since.
  • Quantitative Investment Management's Charles River Laboratories position peaked at $7.12M in Q3 2017.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.